Pharmacists Shouldn't Use TPA Abbreviations


The abbreviations "TPA" and "t-PA" are causing medication mix-ups between alteplase (Activase) and tenecteplase (TNKase).

The abbreviations “TPA” and “t-PA” are causing medication mix-ups between alteplase (Activase) and tenecteplase (TNKase).

Activase is a tissue plasminogen activator originally approved in 1987 for the management of acute myocardial infarction, and later approved for acute ischemic stroke and pulmonary embolism.

Health care professionals commonly refer to Activase as “TPA” or “t-PA.” However, these abbreviations have caused confusion with the shorthand “TNK” for TNKase, another tissue plasminogen activator that was approved in 2000, but only for acute myocardial infarction management.

This confusion is a significant contributing factor to wrong drug errors between Activase and TNKase, according to the FDA and Institute for Safe Medication Practices (ISMP).

In June, for instance, a nurse typed “t” into the automated dispensing cabinet and incorrectly selected tenecteplase instead of alteplase because “alteplase was commonly referred to as tPA.”

This type of error dates back to May 2003, when 2 mix-ups between Activase and TNKase were initially reported by ISMP.

In both cases, nurses assumed that medication orders for “t-PA 8 mg IV” and “t-PA 7 mg IV” for acute ischemic stroke were written as shorthand for TNKase instead of the intended Activase, and they gave the patients 8 mg and 7 mg of TNKase, respectively.

The consequences of such errors include administering a drug not approved for ischemic stroke and also increasing the potential for drug overdose, given that the recommended 9 mg/kg dose of Activase is often higher than the maximum recommended TNKase dose for myocardial infarction.

ISMP noted that a TNKase overdose could increase the risk of intracranial hemorrhage and death.

Because Activase, TNKase, and reteplase (Retavase) are all in the same drug class, using “TPA,” “t-PA,” or “TNK” may cause confusion about the intended drug.

To avoid this, ISMP recommends removing the abbreviations from all standardized order sets, electronic order entry screens, and treatment protocols, and referring to the medications by their brand names, generic names, or both in all verbal and written communication.

Related Videos
Laboratory test tubes and solution with stethoscope background | Image Credit: Shutter2U -
Image credit: Andrea Izzotti
Inflation Reduction Act is shown using the text and the US flag - Image credit: Andrii |
Pharmacy Interior | Image Credit: Tyler Olson -
Male pharmacist selling medications at drugstore to a senior woman customer | Image Credit: Zamrznuti tonovi -
Pharmacist assists senior woman in buying medicine in pharmacy - Image credit: Drazen |
Pharmacy, medicine and senior woman consulting pharmacist on prescription. Healthcare, shopping and elderly female in consultation with medical worker for medication box, pills or product in store - Image credit: C Daniels/ |
Image credit: fidaolga -
Pharmacists checking inventory at hospital pharmacy- Image credit: Jacob Lund |
Young male pharmacist giving prescription medications to senior female customer in a pharmacy | Image Credit: Zamrznuti tonovi -
© 2023 MJH Life Sciences

All rights reserved.